CD19 and systemic sclerosis: The CD19 MFI of SLE-patient-derived B-cells was slightly higher compared to HD- (1.2-fold), IIM- (1.4-fold) and SSc- (1.6-fold) patient-derived B-cells; however, the differences were not significant (Figure 1C).